Pharmacokinetics and metabolism of 123I-BMIPP fatty acid analog in healthy and CD36-deficient subjects

Journal of Nuclear Medicine

Volumn 41, Issue 7, 2000, Pages 1134-1138

  Yoshizumi, Tohru ^a   Nozaki, Shuichi ^b   Fukuchi, Kazuki ^b   Yamasaki, Koichi ^b   Fukuchi, Takahiro ^b   Maruyama, Takao ^b   Tomiyama, Yoshiaki ^b   Yamashita, Shizuya ^b   Nishimura, Tsunehiko ^b   Matsuzawa, Yuji ^b  

^a Minoh City Hospital   (Japan)

^b NONE

Author keywords

123I BMIPP; CD36 deficiency; Long chain fatty acids; Myocardium

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; CD36 ANTIGEN; DRUG METABOLITE; LONG CHAIN FATTY ACID; PHENYLACETIC ACID DERIVATIVE; DIAGNOSTIC AGENT; FATTY ACID; IODOBENZENE; IODOFILTIC ACID; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG ELIMINATION; DRUG METABOLISM; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; FEMALE; HEART MUSCLE; HUMAN; ISOTOPE LABELING; MALE; MEDIASTINUM; PRIORITY JOURNAL; WHOLE BODY SCINTISCANNING; BLOOD; HEART; LIVER; METABOLISM; MIDDLE AGED; SCINTISCANNING; SKELETAL MUSCLE;

ADULT; ANTIGENS, CD36; FATTY ACIDS; FEMALE; HEART; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; LIVER; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOCARDIUM;

EID: 0033623922     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA, Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction and transfusion medicine. Blood 1992;80:1105-1115.
2. Nozaki S, Kashiwagi H, Yamashita S, et al. Reduced uptake of oxidized low density lipoprotein in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest. 1995;96:1859-1865.
3. Abumrad NA, El-Maghrabi MR, Amri EZ, Lopez E, Grialdi PA. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation: homology with human CD36. J Biol Chem. 1993;268:17665-17668.
4. Kashiwagi H, Tomiyama Y, Kosugi S, Shiraga M, et al. Identification of molecular defects in a subject with type ICD36 deficiency. Blood. 1994;83:3545-3552.
5. Kashiwagi H, Tomiyama Y, Honda S, et al. Molecular basis of CD36 deficiency: evidence that a 478C-T substitution (proline90-serine) in CD36 cDNA accounts for CD36 deficiency. J Clin Invest. 1995;95:1040-1046.
6. Kashiwagi H, Tomiyama Y, Nozaki S, et al. A single nucleotide insertion in codon 317 of the CD36 gene leads to CD36 deficiency. Arterioscler Thromb Vasc Biol. 1996;16:1026-1032.
7. Knapp FF Jr, Kropp J. Iodine-123-labeled fatty acids for myocardial single photon emission tomography: current status and future perspectives. Eur J Nucl Med. 1995;22:361-381.
8. 123I-BMIPP). Nucl Med Commun. 1994;15:441-447.
9. Hwang EH, Yamashita A, Takemori H, et al. Absent myocardial I-123 BMIPP uptake in a family. Ann Nucl Med. 1996;10:445-448.
10. Kudoh T, Tamaki N, Magata Y, et al. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP. J Nucl Med. 1997;38:548-553.
11. a-negative subjects whose platelets lack GPIV. Br J Haematol. 1993;84:387-391.
12. Morozumi T, Kusuoka H, Fukuchi K, et al. Myocardial iodine-123-metaiodobenylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med. 1997;38:49-52.
13. Folch J, Less M, Sloane SGH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497-509.
14. Yamamichi Y, Kusuoka H, Morishita K, et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med. 1995;36:1043-1050.
15. a, involved in the refractoriness of HLA-matched platelet transfusion. Vox Sang. 1989;57:213-217.
16. a, on platelet membrane glycoprotein IV. Blood. 1990;75:684-687.
17. Yamamoto N, Akamatsu N, Sakuraba H, Yamazaki H, Tanoue K. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type 1) or the presence (type II) of glycoprotein IV on monocytes. Blood. 1994;83:392-397.
18. Tanaka T, Okamoto F, Sohmiya K, Kawamura K. Lack of myocardial iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) uptake and CD36 abnormality. Jpn Circ J. 1997;61:724-725.
19. Okamoto F, Tanaka T, Sohmiya K, Kawamura K. CD36 abnormality and impaired myocardial long-chain fatty acid uptake in patients with hypertrophic cardiomyopathy. Jpn Circ J. 1998;62:499-504.
20. Yamamoto N, Akamatsu N, Yamazaki H, Tanoue K. Normal aggregations of glycoprotein IV (CD36)-deficient platelets from seven healthy Japanese donors. Br J Haematol. 1992;81:86-92.
21. Tanaka T, Sohmiya K, Kawamura K. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol. 1997;29:121-127.
22. Takeishi Y, Chiba J, Abe S, Tonooka I, Komatani A, Tomoike H. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med. 1992;19:775-782.
23. Schaffer JE, Lodish HF. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell. 1994;79:427-436.
24. Stremmel W, Strohmeyer G, Borchard F, Kochwa S, Berk PD. Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci USA. 1985;82:4-8.